Heart Disease Clinical Trials in New York

Showing 181-200 of 286 trials

RecoverLINK Technology Pilot for HF Patients

NCT02815085

The primary objective is to examine feasibility of incorporating RecoverLINK into the standard of care as a function of (i) user engagement, (ii) user satisfaction, and (iii) workflow efficiency. As secondary objectives, the investigators will collect preliminary data to examine the association between patient engagement with the RecoverLINK app and (i) changes in patient knowledge and behavior, and (ii) hospital readmission(s) at 30, 60, and 90-day time periods post-enrollment.

Heart Failure

RecoverLINK46 participantsStarted Feb 2016

New York, New York, United States

COMPLETEDNA< 1 mile

Exercise and Inflammation

NCT01335737

The purpose of this study is to test the hypothesis that aerobic exercise leads to attenuation of the inflammatory response to lipopolysaccharide (LPS) stimulation.

Cardiovascular Disease

New York State Psychiatric Institute241 participantsStarted Jan 2010

New York, New York, United States

TERMINATEDPHASE2< 1 mile

Combination Therapy Compared With Single-Drug Therapy in Patients With Cardiac Diseases

NCT00115349

The purpose of this study is to determine whether left ventricular function improves more rapidly with deferoxamine (DFO) and deferiprone (L1) combination therapy than with DFO monotherapy in patients with thalassemia and decreased ejection fractions. Secondary aims include evaluating changes in myocardial iron burden using T2\* and estimating the relative incidence and severity of chelator-induced toxicity.

Cardiovascular DiseasesHeart DiseasesBeta-Thalassemia

Carelon Research20 participantsStarted Jun 2005

Los Angeles, California, United States • Oakland, California, United States • Chicago, Illinois, United States +3 more locations

RecoverLINK Technology Pilot for HF Patients

Exercise and Inflammation

Combination Therapy Compared With Single-Drug Therapy in Patients With Cardiac Diseases

Heart Disease Trials in Other Cities

Echocardiography Guided Cardiac Resynchronization Therapy (EchoCRT)

NAVISTAR® THERMOCOOL® Catheter for the Radiofrequency Ablation of Symptomatic Paroxysmal Atrial Fibrillation

Relationship Between Diet, Lifestyle, and the Severity of Coronary Artery Disease

Naltrexone/Bupropion Cardiovascular Outcomes Study

Folic Acid for Vascular Outcome Reduction In Transplantation (FAVORIT)

Targeting Acute Congestion With Tolvaptan in Congestive Heart Failure

Telehealth Management in HF Disparity Patients

Mobile Health Monitoring Solution for Heart Failure Patients

Extension Phase of the Chronicle® Offers Management to Patients With Advanced Signs & Symptoms of Heart Failure Study

Study Dosed With (123I-mIBG) for Identifying Subjects With Heart Failure Who Will Experience an Adverse Cardiac Event

Phase 4 Study to Demonstrate Prognostic Usefulness of AdreView™ Scintigraphy for Identifying Subjects With Heart Failure Who Will Experience Death During 60 Months Follow-up.

AngioDefender Versus Brachial Artery Ultrasound Imaging

Pharmacist-led Group Medical Visits to Help With Diabetes Management

Cardiovascular Improvements With MV ASV Therapy in Heart Failure

A Trial of Behavioral Economic Interventions to Reduce Cardiovascular Disease (CVD) Risk

Pharmacodynamic Evaluation of Switching From Ticagrelor to Prasugrel in Subjects With Stable Coronary Artery Disease

Prospective Multicenter Registry On RadiaTion Dose Estimates Of Cardiac CT AngIOgraphy IN Daily Practice in 2017

Other Conditions in New York